glp-1 receptor agonist

The quick read

What's driving the attention

Searches about GLP-1 receptor agonists like Ozempic and Mounjaro have surged due to concerns about a rare but severe eye disorder linked to these drugs.

Interest in GLP-1 receptor agonists has increased by 600% in Australia, driven by reports linking medications such as Ozempic, Wegovy, and Mounjaro to a rare but severe eye condition called ischemic optic neuropathy. Regulatory authorities like the Australian TGA have issued warnings highlighting potential risks, raising public health concerns.